Will PS Targeting patents be used for TBI? Oh yes....
-----
TED Investigators Receive FDA Letter of Support for Neuroimaging Biomarkers The TED Initiative has reached an important milestone in securing an FDA Letter of Support to further explore neuroimaging prognostic biomarkers that may be used to enrich TBI clinical trials with patients who display particular pathoanatomic features that have been associated with poor short to medium-term outcome following mild TBI. This letter, signed by Dr. Janet Woodcock, Director, FDA Center for Drug Evaluation and Research, represents a significant step forward for the field and an important accomplishment for the TED Initiative. The FDA Letter of Support page can be found here with a direct link to the signed letter. https://tbiendpoints.ucsf.edu
----
Review Multimodal Imaging of Neurometabolic Pathology due to Traumatic Brain Injury
John Darrell Van Horn,1,2,* Avnish Bhattrai,1,2 and Andrei Irimia1,2
Interesting PDF titles above and below
Membrane-Protein Interactions Are Key to Understanding Amyloid Formation
News 
Market Data 
Discover 
